Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. [PDF]
J Psychopharmacol, 2022 Kopra EI +4 more
europepmc +2 more sources
Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms. [PDF]
Chemistry, 2020 Blei F +8 more
europepmc +2 more sources
Specific and Multi-Product Clade I and Clade IV Sesquiterpene Synthases Contribute to the Psilocybe cubensis Volatilome. [PDF]
ChembiochemFive sesquiterpene synthases of Psilocybe cubensis were investigated in vitro and in vivo. CubF is a clade I synthase producing α‐muurolol, whereas clade IV synthases CubG1 and CubG2 produce epi‐isozizaene and β‐duprezianene. Further clade IV synthases CubH and CubI primarily make dauca‐4(11),8‐diene and β‐barbatene, respectively.
Schober S +8 more
europepmc +2 more sources
Manic episode following psilocybin use in a man with bipolar II disorder: a case report
Frontiers in Psychiatry, 2023 There has been an increase in research on the topic of psychedelic substances and their effects as treatment options in neuropsychiatric conditions. Psilocybin is a psychedelic drug that has recently garnered increased interest as an effective treatment ...
Haniya J. Halim +3 more
doaj +1 more source
Therapeutic use of psilocybin: Practical considerations for dosing and administration
Frontiers in Psychiatry, 2022 The interest in psilocybin as a therapeutic approach has grown exponentially in recent years. Despite increasing access, there remains a lack of practical guidance on the topic for health care professionals.
Caroline A. MacCallum +3 more
doaj +1 more source
Magic truffle intoxication: A case report
Emergency Care Journal, 2022 Unusual forms of hallucinogenic mushrooms are emerging, which may delay diagnosis and compromise optimal management. Here, we discuss clinical and biological findings in a case of “magic mushroom” intoxication in a 20-year-old man who was brought to ...
Brendan Le Daré +4 more
doaj +1 more source
Electrical spiking of psilocybin fungi
Communicative & Integrative Biology, 2022 Psilocybin fungi, aka “magic” mushrooms, are well known for inducing colorful and visionary states of mind. Such psychoactive properties and the ease of cultivating their basidiocarps within low-tech setups make psilocybin fungi promising pharmacological
Antoni Gandia, Andrew Adamatzky
doaj +1 more source
Scientific Reports, 2020 Prevalence of major depression in people with chronic heart failure is higher than in normal populations. Depression in heart failure has become a major issue.
Sanah M. Nkadimeng +2 more
doaj +1 more source
The Therapeutic Potential of Psilocybin
Molecules, 2021 The psychedelic effects of some plants and fungi have been known and deliberately exploited by humans for thousands of years. Fungi, particularly mushrooms, are the principal source of naturally occurring psychedelics.
Henry Lowe +7 more
doaj +1 more source
Exploring Psilocybe spp. mycelium and fruiting body chemistry for potential therapeutic compounds
Frontiers in Fungal Biology, 2023 Psilocybe mushrooms, otherwise known as “magic” mushrooms, owe their psychedelic effect to psilocin, a serotonin subtype 2A (5-HT2A) receptor agonist and metabolite of psilocybin, the primary indole alkaloid found in Psilocybe species. Metabolomics is an
Adam Waldbillig +4 more
doaj +1 more source